November 14, 2019
FDA: Class I recall of Zimmer Biomet’s ROSA Brain 3.0 Robotic Surgery System
Editor's Note
The Food & Drug Administration on November 7 identified the recall by Zimmer Biomet of its ROSA Brain 3.0 Robotic Surgery System as Class I, the most serious.
The recall was initiated because of a software issue that incorrectly positions the robotic arm. The company has received five complaints related to this issue, including one patient injury. No deaths have been reported.
Distribution dates for the system were April 8, 2016, to March 19, 2019.
Free Daily News
- GLP-1 agonists linked to food retention in EGD, but not combined EGD-colonoscopy
- Healthcare employment up in September
- World's first all-plastic ankle replacement offers hope for patients with metal allergies
- AAMI, CTA partners to develop healthcare AI standards
- ECRI issues guidance to address medical supply shortages caused by Hurricane Helene, dockworkers’ strike
- FDA designates Class 1 recall for IPV therapy system
- Study: Early detection of atherosclerosis linked to lower mortality risk
- Repeal of CON laws for ASCs expands healthcare access, number of facilities in rural areas
- Spatial computing trial shows promise for enhancing OR efficiency, reducing strain on surgeons
- Vice presidential debate highlights healthcare, abortion policy differences
© Access Intelligence, LLC. All rights reserved. |
Privacy Policy |
Cookie Settings |
Diversity, Equity, Inclusion & Belonging |
Accessibility Statement